Clinical Trials in Houston

Showing 3361-3380 of 15,366 trials

Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial

NCT04883671

The aim of this study is to learn whether the early initiation of a specialized and focused type of radiation called stereotactic body radiation therapy (SBRT) will impact the progression of advanced adenoid cystic carcinoma, quality of life, and overall survival. The name(s) of the study intervention involved in this study is: * Stereotactic Body Radiation Therapy (SBRT)

Adenoid Cystic CarcinomaMetastatic Adenoid Cystic Carcinoma

Dana-Farber Cancer Institute32 participantsStarted Dec 2021

San Francisco, California, United States • Chicago, Illinois, United States • Boston, Massachusetts, United States +2 more locations

RECRUITINGPhase 1< 1 mile

R-2487 in Patients With Rheumatoid Arthritis

NCT05961592

The goal of this study is to determine the safety and tolerability of orally taken probiotic (R-2487) in patients with Rheumatoid Arthritis. Patients will take an oral dosage of probiotic (R-2487) and physicians will assess and measure their Rheumatoid Arthritis. Blood and fecal evaluations of inflammation and assessment of probiotic (R-2487) on fecal level will also be measured.

Arthritis, Rheumatoid

Rise Therapeutics LLC73 participantsStarted Oct 2023

San Diego, California, United States • Doral, Florida, United States • Miami, Florida, United States +2 more locations

Stereotactic Body Radiotherapy (SBRT) for Early Treatment of Oligometastatic Adenoid Cystic Carcinoma: The SOLAR Trial

R-2487 in Patients With Rheumatoid Arthritis

Find Trials by Condition in Houston

CAB-AXL-ADC Safety and Efficacy Study in Adult and Adolescent Patients With Sarcoma

Electronic KIDCLOT Interactive Thrombosis/Thrombophilia Education; A Quality Assurance Initiative

EchoTip AcuCore Post-Market Clinical Study

A Patient Registry Study for Patients Treated With Voretigene Neparvovec in US

IO Vancomycin in TSA

First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer

Do Biomarkers Predict Response to a Pediatric Chronic Pain Symptom Management Program?

A Study of Orforglipron (LY3502970) Compared With Semaglutide in Participants With Type 2 Diabetes Inadequately Controlled With Metformin

Dose-Reduced Consolidation Radiation Therapy in Patients With Diffuse Large B-cell Lymphoma

A Study to Evaluate Mavacamten Impact on Myocardial Structure in Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Assessing Compliance With Mercaptopurine Treatment in Younger Patients With Acute Lymphoblastic Leukemia in First Remission

A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors

A Study to Evaluate the Efficacy and Safety of Imsidolimab (ANB019) in the Treatment of Participants With Acne Vulgaris

4D-150 in Patients With Diabetic Macular Edema

A Study of Olomorasib (LY3537982) in Participants With Hepatic Impairment and Healthy Participants

Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study

Safety and Pharmacokinetics of Ceftolozane/Tazobactam in Pediatric Participants With Nosocomial Pneumonia (MK-7625A-036)

Immune Profile of Acute Myeloid Leukemia Patients Receiving Azacitidine Plus Venetoclax Induction Chemotherapy